🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors market the substance there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Removal

According to the social media company, the platform has removed violative material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of members, populated with images of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.

After moments of joining one group, a vendor posted contact information, where most transactions take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Information and Pricing

Within these groups, posts show black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it regularly moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious health risks”.